Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer

BACKGROUND: Immunotherapy alone (mono-IT) or combined with chemotherapy (chemo-IT) has recently become the cornerstone of first-line treatment for advanced non-small cell lung cancer (NSCLC) patients. Here, real-world outcomes of first-line mono-IT and chemo-IT of advanced NSCLC treated within routi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelicon, Veronika, Cufer, Tanja, Knez, Lea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316645/
https://www.ncbi.nlm.nih.gov/pubmed/37404771
http://dx.doi.org/10.3389/fonc.2023.1182748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316645/
https://www.ncbi.nlm.nih.gov/pubmed/37404771
http://dx.doi.org/10.3389/fonc.2023.1182748

Ejemplares similares